BioSig to Present at the 25th Annual International AF Symposium

PURE EP(tm) System to be highlighted in a Spotlight session by Andrea Natale, M.D., Texas Cardiac Arrhythmia Institute Westport, CT, Jan. 21, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company developing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that the Company will be exhibiting at the 25th Annual…